Hua Liao, PhD
Hua Liao, Ph.D. oversees preclinical biology and biochemistry as well as biologics drug discovery at Orange Grove Bio ("OGB"). He has over 20 years of experience in drug discovery research in the biotech and pharmaceutical industry with strong expertise and broad knowledge in the areas of preclinical biology, biochemistry and biophysics, biomarker discovery, DMPK, and biotherapeutics. He has worked on numerous drug discovery projects in the areas of oncology and immunology, including both small molecule and protein therapeutics projects, and has contributed to the discovery and development of serval marketed therapeutics. Dr. Liao earned his Ph.D. degree in Biochemistry from The Ohio State University and worked as a postdoctoral fellow at Harvard Medical School.